X-twitter Linkedin Facebook-f Vimeo

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Kingfisher plc

Kingfisher raises full-year guidance after H1 profit growth

Kingfisher reported a 9.9% rise in adjusted pre-tax profit to £404m for the six months ended 31 July 2026, supported by higher gross margins and cost control. The group upgraded..
AstraZeneca

AstraZeneca’s Klygefa recommended for EU approval in generalised myasthenia gravis

The EMA’s CHMP has recommended Klygefa (gefurulimab) for approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase III PREVAIL trial results...
JD

JD Sports targets Mexican growth with 140+ store franchise expansion

JD Sports has partnered with Grupo Axo to launch in Mexico from 2027, giving the Group access to a large, growing sportswear market while advancing its ‘JD Brand First’ strategy..
Next Plc

NEXT raises full-year profit guidance after strong first-half growth

NEXT reported a 10.5% rise in first-half Group profit before tax to £569m and increased its full-year profit guidance to £1.255bn. The retailer also declared an interim dividend of 98p..
BTRW

Barratt Redrow delivers 17,667 homes as FY26 revenue rises 6.6%

Barratt Redrow reported £6.06bn of revenue and £572.8m of adjusted profit before tax for FY26, while completions increased 5% to 17,667 homes. The group completed its Redrow integration and revised..
BAB

Babcock trading on track as FY27 outlook remains unchanged

Babcock reported good momentum in the first five months of FY27, with strong Nuclear and Aviation performance, robust defence demand and full-year and medium-term guidance maintained...
GSK Plc

GSK to acquire Chimagen Trispecific T-cell engager for multiple myeloma

GSK has agreed to acquire global rights to Chimagen Biosciences’ trispecific T-cell engager for multiple myeloma in a deal worth up to $750 million. The programme is expected to enter..
Associated British Foods plc

Associated British Foods expects FY2026 profit in line as Primark expands digital strategy

Associated British Foods expects full-year adjusted operating profit to be broadly in line with previous guidance, with earnings per share ahead of expectations. Primark sales are set to rise around..
Metlen Energy & Metals

METLEN sells Tamarico II solar and battery storage project in Chile

METLEN has agreed to sell the Tamarico II hybrid renewable energy project in Chile’s Atacama Region to Copec Flux. The project combines 165 MW of solar capacity with a 725..
GSK Shingrex

GSK’s Shingrix prefilled syringe approved in Japan

Japan’s health ministry has approved a ready-to-use prefilled syringe presentation of GSK’s Shingrix shingles vaccine, simplifying preparation and administration for healthcare professionals...
AstraZeneca

AstraZeneca’s Etcamah approved in US for ESR1-mutated advanced breast cancer

The FDA has approved Etcamah (camizestrant) with a CDK4/6 inhibitor for HR-positive, HER2-negative advanced breast cancer after detection of an emerging ESR1 mutation, based on Phase III SERENA-6 results showing..
SDLF

Standard Life H1 operating profit rises 25% as 2026 targets remain on track

Standard Life reported £563m of adjusted operating profit and £745m of operating cash generation in H1 2026, with all full-year targets on track...
LMP

LondonMetric reports £105m of portfolio investment activity

LondonMetric has completed or agreed £105 million of investment activity since July, including £85 million of asset sales, while progressing £140 million of further acquisitions focused on long-let properties...
ITH

Ithaca Energy to join FTSE 100 Index

Ithaca Energy has confirmed its promotion to the FTSE 100, effective 21 September 2026, following FTSE Russell’s latest index review...
MNG

M&G delivers 15% rise in adjusted operating profit in first half of 2026

M&G reported adjusted operating profit of £435 million for the six months ended 30 June 2026, up 15% year on year, alongside £2.4 billion of net inflows from open business..
BP

BP appoints Ian Tyler as Chair

Ian Tyler has been appointed Chair of bp with immediate effect, after serving as Interim Chair since May 2026. Dame Amanda Blanc will step down from the board once a..
SSE

SSE hosts investor event focused on SSEN Transmission

SSE is hosting analysts and institutional investors in Aberdeen for an update on SSEN Transmission’s £29bn RIIO-T3 investment plan, including project delivery, asset management, finance and regulation...
PRU

Prudential declares 2026 first interim dividend of 8.88 US cents per share

Prudential has set out the timetable, currency election deadlines and scrip dividend arrangements for its 2026 first interim dividend...
AstraZeneca

AstraZeneca’s Tezspire meets key endpoints in Phase III EoE trial

AstraZeneca has reported positive Phase III CROSSING trial results for Tezspire in eosinophilic oesophagitis, with benefits sustained to week 52...
CTEC

Convatec appoints Jens Viebke as Non-Executive Director

Convatec has appointed Dr Jens Viebke as a Non-Executive Director with immediate effect and added him to the Remuneration Committee...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Kingfisher plc

Kingfisher raises full-year guidance after H1 profit growth

Kingfisher reported a 9.9% rise in adjusted pre-tax profit to £404m for the six months ended 31 July 2026, supported by higher gross margins and cost control. The group upgraded its full-year profit and free cash flow guidance...
AstraZeneca

AstraZeneca’s Klygefa recommended for EU approval in generalised myasthenia gravis

The EMA’s CHMP has recommended Klygefa (gefurulimab) for approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase III PREVAIL trial results...
JD

JD Sports targets Mexican growth with 140+ store franchise expansion

JD Sports has partnered with Grupo Axo to launch in Mexico from 2027, giving the Group access to a large, growing sportswear market while advancing its ‘JD Brand First’ strategy through a franchise-led model...
Next Plc

NEXT raises full-year profit guidance after strong first-half growth

NEXT reported a 10.5% rise in first-half Group profit before tax to £569m and increased its full-year profit guidance to £1.255bn. The retailer also declared an interim dividend of 98p per share...
BTRW

Barratt Redrow delivers 17,667 homes as FY26 revenue rises 6.6%

Barratt Redrow reported £6.06bn of revenue and £572.8m of adjusted profit before tax for FY26, while completions increased 5% to 17,667 homes. The group completed its Redrow integration and revised FY27 completion guidance to 17,500–17,900 homes...
BAB

Babcock trading on track as FY27 outlook remains unchanged

Babcock reported good momentum in the first five months of FY27, with strong Nuclear and Aviation performance, robust defence demand and full-year and medium-term guidance maintained...
GSK Plc

GSK to acquire Chimagen Trispecific T-cell engager for multiple myeloma

GSK has agreed to acquire global rights to Chimagen Biosciences’ trispecific T-cell engager for multiple myeloma in a deal worth up to $750 million. The programme is expected to enter Phase I trials in 2027...
Associated British Foods plc

Associated British Foods expects FY2026 profit in line as Primark expands digital strategy

Associated British Foods expects full-year adjusted operating profit to be broadly in line with previous guidance, with earnings per share ahead of expectations. Primark sales are set to rise around 2%, while the retailer plans to introduce home delivery in Great Britain and continue investing in value, marketing and digital growth...
Metlen Energy & Metals

METLEN sells Tamarico II solar and battery storage project in Chile

METLEN has agreed to sell the Tamarico II hybrid renewable energy project in Chile’s Atacama Region to Copec Flux. The project combines 165 MW of solar capacity with a 725 MWh battery energy storage system, expandable to 925 MWh...
GSK Shingrex

GSK’s Shingrix prefilled syringe approved in Japan

Japan’s health ministry has approved a ready-to-use prefilled syringe presentation of GSK’s Shingrix shingles vaccine, simplifying preparation and administration for healthcare professionals...
AstraZeneca

AstraZeneca’s Etcamah approved in US for ESR1-mutated advanced breast cancer

The FDA has approved Etcamah (camizestrant) with a CDK4/6 inhibitor for HR-positive, HER2-negative advanced breast cancer after detection of an emerging ESR1 mutation, based on Phase III SERENA-6 results showing a 56% reduction in the risk of disease progression or death...
SDLF

Standard Life H1 operating profit rises 25% as 2026 targets remain on track

Standard Life reported £563m of adjusted operating profit and £745m of operating cash generation in H1 2026, with all full-year targets on track...
LMP

LondonMetric reports £105m of portfolio investment activity

LondonMetric has completed or agreed £105 million of investment activity since July, including £85 million of asset sales, while progressing £140 million of further acquisitions focused on long-let properties...
ITH

Ithaca Energy to join FTSE 100 Index

Ithaca Energy has confirmed its promotion to the FTSE 100, effective 21 September 2026, following FTSE Russell’s latest index review...
MNG

M&G delivers 15% rise in adjusted operating profit in first half of 2026

M&G reported adjusted operating profit of £435 million for the six months ended 30 June 2026, up 15% year on year, alongside £2.4 billion of net inflows from open business and a Solvency II coverage ratio of 247%...
BP

BP appoints Ian Tyler as Chair

Ian Tyler has been appointed Chair of bp with immediate effect, after serving as Interim Chair since May 2026. Dame Amanda Blanc will step down from the board once a successor is appointed as Senior Independent Director...
SSE

SSE hosts investor event focused on SSEN Transmission

SSE is hosting analysts and institutional investors in Aberdeen for an update on SSEN Transmission’s £29bn RIIO-T3 investment plan, including project delivery, asset management, finance and regulation...
PRU

Prudential declares 2026 first interim dividend of 8.88 US cents per share

Prudential has set out the timetable, currency election deadlines and scrip dividend arrangements for its 2026 first interim dividend...
AstraZeneca

AstraZeneca’s Tezspire meets key endpoints in Phase III EoE trial

AstraZeneca has reported positive Phase III CROSSING trial results for Tezspire in eosinophilic oesophagitis, with benefits sustained to week 52...
CTEC

Convatec appoints Jens Viebke as Non-Executive Director

Convatec has appointed Dr Jens Viebke as a Non-Executive Director with immediate effect and added him to the Remuneration Committee...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple